USPTO serial 99337421
Reviewed by CopyMark Law Group
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $125
Columbia, MD, US
Columbia, MD, US
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew J. Ferren
Andrew J. Ferren Goulston & Storrs PCOne Post Office Square25th FloorBoston, MA 02109| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Software as a service (SaaS) services featuring software using artificial intelligence to improve the design and operational efficiency of clinical trials by means of generating actionable insights, predictions, and workflow automation; Software as a service (SaaS) services featuring software using artificial intelligence to extract structured and unstructured data from clinical trial protocols to create, de-identify, encrypt, standardize and tokenize machine readable data for use in the field of clinical research; Software as a service (SaaS) featuring software for use in providing a data clean room enabling researchers to securely access and analyze digitized clinical trial protocol data for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence to optimize clinical research protocols and study feasibility by benchmarking a given protocol against the operational outcomes of similar past protocols for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence that enables researchers to engage in predictive planning to model the budget, timeline, enrollment, site performance, and investigator trends for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence to automate Institutional Review Board (IRB) workflow for submission validation, conversational guidance and digital protocol delivery for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence to enable research study startup workflows that digitize artifacts, research site communications, predictive planning, and regulatory tracking for accelerated initiation of research sites for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence and integrated workflow automation to plan, track, and manage clinical trial operations at research sites effectively with real-time visibility to identify opportunities for further efficiency; Providing temporary use of online non-downloadable chatbot software using artificial intelligence to respond to natural language queries from researchers with charts, summaries, and follow-up prompts for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence to create research data visualizations that automatically generate dashboards, graphing, and charting for evidence-backed insights for use in the field of clinical research; Software as a service (SaaS) services featuring software using artificial intelligence to forecast and recommend actions that enable researchers to improve the design, planning, and execution of clinical trials for use in the field of clinical research | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 25, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 29, 2026 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| May 29, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 29, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 30, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 4, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 4, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 29, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 2, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 1, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 1, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 1, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 8, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 8, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 1, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 14, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 14, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 14, 2025 | NWAP | NEW APPLICATION ENTERED | — |